OJHAS Vol. 11, Issue 1:
(Jan-Mar 2012) |
|
|
Health Care Challenges of
Hereditary Common Hematological Disorders in Odisha, India |
|
RS Balgir,
Division of Human Genetics, Regional Medical Research
Centre (ICMR), Opposite Kalinga Hospital, Chandrasekharpur, Bhubaneswar-751
023, Odisha. |
|
|
|
|
|
|
|
|
|
Address for Correspondence |
Dr. RS Balgir,
Scientist
F/Deputy Director (Senior Grade) & Head, Department of Biochemistry,
Regional Medical Research Centre for Tribals (Indian Council of Medical
Research), Nagpur Road, Jabalpur-482 003, Madhya Pradesh, Central India.
E-mail:
balgirrs@yahoo.co.in |
|
|
|
|
Balgir RS. Health Care Challenges of
Hereditary Common Hematological Disorders in Odisha, India. Online J Health Allied Scs.
2012;11(1):2 |
|
|
Submitted: Nov 18,
2011; Suggested revision: Dec 10, 2012; Revised: Jan 10, 2012;
Accepted: Mar 20, 2012; Published: Apr 15, 2012 |
|
|
|
|
|
|
|
|
Abstract: |
Medical Genetics over the past few decades have emerged as an important
and powerful medical specialty with increasing appreciation of its role
and function in the biomedical sciences. This emergence is related to
a great extent to the progress in the Human Genome Project, which promises
wide-ranging applications in the diagnosis, treatment and prevention
of human diseases. Nevertheless, the discussion on the role of genetics
as the preventive medicine and public health care also lead to ethical,
legal and social concerns about general applicability of genetic testing
in the ethnic communities. The interpretation of prevention in the context
of genetic diseases leads to the unavoidable discussions of genetic
engineering, stem cell transplantation, prenatal diagnosis and selective
termination of pregnancy, as well as broader concerns about discrimination
in health care coverage, gender bias, employment and insurance in the
society. In Indian communities where consanguineous marriage is widely
practiced, recessive/x-linked genetic disorders such as sickle cell
disease and beta-thalassemia, will continue to gain greater prominence
in the overall spectrum of ill health. Developing an understanding of
these changes will require a wide-ranging and multidisciplinary investigative
approach for which public health genetics is ideally suited to conditions
in Odisha.
Key Words:
Medical Genetics; Sickle Cell Disease; b-Thalassemia; G6PD Deficiency;
Public Health Burden; Odisha.
|
|
The
human population of the state of Odisha is comprised of many subgroups,
divided by geography, language, religion, castes (patrilineages), and
scheduled tribes with endogamous norms of marriage. The net effect of
endogamous practices has been the creation of multiple genetic isolates
with individual profile of genetic and erythrocytic disorders (1,2),
but to date the clinical consequences of this highly complex differentiation
have been largely ignored.(3,4) In contrast, the topic of consanguinity
continues to attract attention among medical and population geneticists,
clinicians, biological anthropologists, social scientists and public
health administrators in the state of Odisha.(5,6) The significant
progress made in improving childhood nutritional status and combating
infectious diseases means that genetic and erythrocytic disorders have
assumed ever-increasing importance in the state of Odisha.
The
primary prevention of human diseases in the context of medical genetics
refers to prevention of disease entity for which the gene or genes in
question play a major role.(7) How can that occur? While gene therapy
may become appropriate to correct certain deficient gene products leading
to human disease, primary prevention of many multifactorial human diseases will
entail understanding and interruption of the environmental cofactors among
individuals who inherit genetic susceptibility (polymorphisms or disease
mutations). The ultimate and powerful realization could be the driving force in
medicine, public health and society at large to accept once and for all our
genetic make-up and direct our focus and attention to the prevention of human
diseases and suffering by targeting our disease prevention strategies to
modifiable risk factors (e.g. dietary factors) according to each and everyone's
unique biological susceptibilities. Such a realization could also be the engine
that drives the much-needed reform in our health care system.(8, 9)
The
advent of molecular testing has been a great boon for the people, as
this has enabled antenatal diagnosis of many burdensome disorders, which
were earlier not identifiable in the fetus. Molecular diagnosis is now
possible for a large number of genetic disorders. At present, there
are three established medical colleges at Cuttack, Burla and Berhampur
in the state of Odisha. Medical colleges located at Berhampur and Cuttack
cater to the health care needs of coastal Odisha, whereas, at Burla
it covers the whole of Western Odisha. The 11th Five Year
Plan is being implemented to open a branch of All India Institute of
Medical Sciences, Bhubaneswar and three medical colleges at Rourkela,
Bhawanipatna and Koraput in Odisha. Although the health infrastructures
and treatment facilities are inadequate in Odisha (10), it is further
marred by the lack of any Medical Genetics faculty and facilities in
the state.
Among
the various common genetic diseases such as cancer, cardio-vascular
diseases, diabetes, hemophilia, color blindness, chromosomal aberrations,
congenital malformations, inborn errors of metabolism, psychiatric anomalies,
etc. among others prevalent in Odisha (11), the sickle cell anemia (12-14),
β thalassemia
and glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency are the
most dreadful ones.(15) These ailments in the children are accounted
for defective genes inherited from the parents.(16-18) The patient
has to undergo various trials and tribulations including frequent blood
transfusions and painful injections from time to time for the normal
survival of the affected offspring.(3,12-14)
With
the ever-increasing disorders of blood like sickle cell disease,
β
thalassemia
and G6PD deficiency in the populations of Odisha, the detection, treatment
and management (12-14) of these genetic disorders have become a cause
of worry for the medical practitioners (16,17), researchers as well
as state’s health policy makers, administration and the welfare organizations
including the NGOs.(19,20)
In
Odisha as a tradition and convention, the horoscopes of both to be partners
are generally matched before the finalization of a marriage of a couple.
But now it has been over emphasized and realized that rather than the
horoscope, the blood of the couple should be matched to prevent the
severe hereditary disorders in the offspring/family and community.(7,21,22)
|
|
|
|
|
|
|
|
Strategy of Management of Genetic Diseases |
For
the strategy of management of genetic diseases, the intake of patients
into the program will occur by two routes: through planned genetic screening
and through individual referrals for medical diagnosis and genetic counseling
(7, 21).
Genetic screening has
three major objectives:
a). To provide opportunity for medical intervention
(treatment)
b). To provide opportunity for counseling about reproductive
options; and
c). To collect research data pertinent to public health
policy and basic knowledge and natural history of a disease.
Medical Genetics
Every
individual carries two sets of genes inherited each from biological
parents. If one set of genes were defective one, the person would be
a carrier or trait for sickle cell disease/ beta-thalassemia. It is
surprising that the carrier parents are as normal as any other parent
without this genetic defect. In this case, as another set of genes is
normal, the carrier can still lead a healthy life. Such carriers are
known as sickle cell trait/thalassemia minor. However, when a child
has “carrier father” and “carrier mother”, the chances of inheriting
defective genes from both parents are 25 percent in every pregnancy
resulting in the disease. Thus, the children of carrier parents have
25 percent chance of having a sickle cell disorder/β-thalassemia in every
pregnancy. In this case, it is known as sickle cell disease/
β-thalassemia major. The β-thalassemia
is prevalent in Mediterranean countries and is
also known as “Mediterranean anemia”, whereas, the sickle cell disease
is prevalent in African countries and other tropical and subtropical
parts of the world. If any married couple comes to know through testing
the blood regarding the carrier status, he/she should advise immediately
to the spouse to get tested for these genetic disorders. Carrier parents
are generally advised to avoid producing their own children, but can
adopt a child of his/her brother/sister, relative or friend. They are
given genetic counseling at each pregnancy for prenatal diagnosis, adoption
of a child of relative or of any friend.(21-23) This is because of
the fact that repeated blood transfusions, chelation therapy, maintenance
the child under aseptic conditions, frequent travel and loss of working
hours, exorbitant cost of medicines, expensive bringing up, etc. are
too burdensome for an average or mediocre family.(4)
The
G6PD enzyme is one of the most important enzymes in the red cells, which
protects the red cells from oxidative damage. It is an x-linked inherited
enzyme in humans. A person who is deficient (Xo) sometimes
suddenly gets severe anemia and jaundice after exposure to certain infections
or after taking certain drugs or medicines. Generally, the neonates
deficient of this enzyme have risk of developing severe jaundice.(22,23)
Some patients also excrete black urine after taking certain drugs/antimalarials.(15)
This enzyme deficiency is a sex-linked (X) hereditary disorder,
which is present at birth and cannot be corrected during lifetime of
an individual. Gene is located on the X chromosome. Males have only
one X chromosome, the other being Y chromosome, however, females have
two X-chromosomes, therefore, deficiency is expressed in hemizygous
(XoY) condition in males and heterozygous (XoX)
or homozygous (XoXo) condition in females depending
upon the number of X chromosome carrying defective gene. If a G6PD deficient
man marries a woman without defective gene, all his daughters will have
only one defective X from father and one normal X from the mother. In
this case, all daughters will be carriers and all sons will be normal
(for details see references.(15,22,23)
Hemoglobin
Human
blood contains a remarkable variety of cells, each precisely tailored
to its own vital function. Blood is made up of erythrocytes or red blood
corpuscles (RBC) in slightly yellowish-colored liquid called plasma.
These RBCs are constantly produced in the bone marrow of the human body.
RBCs contain hemoglobin, the messenger carrying oxygen essential for
life from the lungs to all parts of the body. Hemoglobin contains iron.
RBCs are constantly broken down after 90-120 days due to wear and tear
and the remaining iron left over in the process is reutilized by the
bone marrow to reproduce fresh RBCs.(24) Sometimes this unutilized
iron in circulation leads to hyperbilirubinemia and damage to the liver,
kidney and other vital body organs. Therefore, the elimination of this
excess iron overload by chelation therapy after 10-15 blood transfusions
is highly essential.(22,23,25)
Symptoms
In
case of β-thalassemia
major, which is a genetic blood disease, bone
marrow fails to produce normal RBCs resulting in acute dearth of hemoglobin.
In the case of sickle cell disease, altogether structurally defective
sickle hemoglobin (Hb S) is produced. Sometimes, the combinations of
both these genetic abnormalities occur in an individual and it is known
as sickle cell- β-thalassemia (3). The outcome of these hemoglobin abnormalities
will be failure to maintain regular oxygen supply, resulting in early
death. Defective formation of globin chain in hemoglobin molecule of
human red blood cells causes β-thalassemia major, resulting in anemia, jaundice, yellow
eyes, joint or abdominal pains, body ache, and weakness throughout life.(23,26) The imbalanced globin chain synthesis of hemoglobin molecule
damages the red cells in blood quickly and results in anemia, dysfunction
of vital organs and profound physical and mental deformities.
Children
with sickle cell disease/ β-thalassemia
major are quite normal during birth. The symptoms
manifest between three to twelve months of age. They turn pale (anemic)
with jaundice and show little inclination for food. They also hardly
sleep. Absence of timely medical intervention may prove fatal.
Treatment
At
present, available treatment for thalassemia is regular blood transfusion.
This kind of blood transfusion is known as “hyper transfusion”.
The sickle cell disease can be managed without repeated blood transfusions
even under low concentration of hemoglobin by carefully taking the preventive
measures.(21-23) As the iron produced during the breaking process of
the transfused blood will not be reutilized due to malfunctioning of
bone marrow, it gets deposited in vital organs like liver and heart
causing immense damage to them.(12-14) Hence, it is very essential that this iron must be removed from
the body. Failure to do so will shorten the life span of the patient.
The β-thalassemia
major is a condition where patients need blood transfusions throughout
their lives, as their bone marrow is unable to produce red blood cells.
These transfusions result in an iron overload on various organs and
patient does not grow normally. The drug “Desferal” in the form
of injection has to be administered everyday to eliminate the excess
iron deposited in the body.
Curative Therapies
Stem
cell and bone marrow transplantations and gene therapy are other possible
alternatives mooted by the experts. Bone marrow transplantation seems
to be a far-fetched one as it can be carried out only on a limited number
of patients for want of suitable donors. Cord Blood is an alternative
to bone marrow transplantation. The blood cells develop from the master
cell, the stem cell. Knowledge of these cells has opened the doors to
promising therapies for dreaded diseases like Cancer, thalassemia, etc.
The umbilical cord connects the baby to the placenta supplying blood
and nutrients. After birth, it is usually discarded. However, stem cells
from the cord blood are used for treating cancers and blood disorders.
Cord blood comprises of red and white blood cells that carry iron, oxygen
and as a result fight any infection. Stem cells are immature cells that
can develop into red cells, white cells or platelets. Bone marrow is
used for such transplants because it contains undifferentiated or immature
cells.
Collecting
and preserving a baby’s cord blood properly is highly important. The
procedure followed for collecting cord blood is simple. Immediately
after a baby is born, the umbilical cord is clamped. The baby is then
removed from the area and the placenta is placed in a sterile supporting
structure in such a manner that the umbilical cord hangs through the
support. The cord is cleansed with beta-dine and alcohol. Blood is drawn
by inserting a needle into the umbilical vein and stored in a standard
blood-collecting bag containing nutrients and anticoagulant. The average
yield is approximately 75 milliliters. Stem cells research is a promising
field of biological research and medicine based on the potential of
the cells, which theoretically can be directed to form any tissue in
the human body. These cells represent a rich source of material that
could be used for transplantation.
Gene
therapy may be effective by implanting healthy genes into patient’s
bone marrow cells. Trials for such a therapy are still on. In future
such a technology may yield promising results. Stem cells are a kind
of master cell that have the potential to grow into various tissues.
Sometimes, taken from embryos, their power to differentiate into various
cell types is unlimited. Embryonic stem cells are unusual in being much
less immunogenic than other cell types. They also appear not to cause
potentially deadly transplant responses such as rejection. Although
the potential is there to grow new tissues and even organs to treat
diseases such as Parkinson’s disease, Alzheimer’s disease or cancer,
no one quite understands how to do it yet. Some people want them only
to become pancreatic beta cells that make insulin to cure children with
type-1 diabetes. But opponents and some religious and anti-abortion
groups say that any use of a human embryo, however, tiny, amounts to
murder and is unethical.
Prenatal Diagnosis
The β-thalassemia
major can be prevented during prenatal stage if the biopsy study of
fetus, chorionic villi or amniotic fluid is done between 10-12 weeks
of the pregnancy.(21-23) This tissue sample taken is studied for genetic
abnormalities. If the genes of the tissue indicate that the baby is
going to suffer from the disease, then the couple is advised to terminate
the pregnancy. If the genes tested to be are carrier or normal, then
the pregnancy is allowed to continue. However, such facilities are available
only in Metro cities in India.
Thalassemic Woman May Become Mother!
Musharat
Wahab, the first thalassemic woman in the country to conceive, who has
delivered a baby girl after a Caesarian section at the St. George’s
Hospital, Mumbai on 1st December 2000. Her baby brings hope
to thalassemic patients across India as experts say that there is a
slim chance of female patients conceiving at all as they fail to develop
secondary sexual characteristics. Musharat was married in February and
conceived a couple of months later. Throughout her life, she had been
taking regular transfusions at the blood bank in this hospital and all
care was taken to see that her hemoglobin level was normal. This resulted
in her greater maturity and her pregnancy.
Studies
have revealed that the tribal populations of Western and Southern parts
of Odisha are prone to sickle cell anemia and G6PD deficiency; the coastal
region is mostly vulnerable to β-thalassemia and G6PD deficiency. Communities such as Khandayat,
Chasa, Kulita, Agharia, Brahmin, Karan, Teli, Gauda, Dhoba, Pano, Ganda,
Dom, Gond, Kharia, Paraja, Bhatra, Munda, Santal, etc. are at risk and
highly vulnerable to these genetic disorders in Odisha state. Most of
these communities practise consanguinity (27), which further increases
the homozygosity and severity. This also leads to high morbidity, mortality
and fetal wastage in Odisha.(4,26) Initial studies in Odisha state
pertaining to sickle cell disease were carried out by anthropologists.(28,29)
Although
the High Performance Liquid Chromatography (HPLC) machine used for the
detection of sickle cell disease or beta-thalassemia is less time consuming
and reliable to some extents over the traditional method of electrophoresis,
but it is not confirmatory test over molecular techniques, which determine
the exact defect in an individual. Moreover, it is costly to poorer
sections of the society who are at high risk, most vulnerable and cannot
afford to pay money. These genetic disorders are rampant among the poor
section of the people.(19,20)
It
is deplorable that cases of sickle cell anemia and β-thalassemia major require repeated blood transfusion to maintain
their survival under healthy conditions. The total life span of the
RBCs on an average varies from 90 to 120 days. Unfortunately in the
state of Odisha, these patients are given blood transfusions before
the actual diagnosis is made. The amount of blood transfused is also
sometimes influences the laboratory investigation report. Sometimes,
the attending doctors refer the suspected cases of above blood disorders
for electrophoresis and hematological investigations immediately after
the blood transfusion. The transfused blood interferes with the accurate
diagnosis of the patient. This leads to misdiagnosis of the cases where
the past history is not taken. Sometimes the parents of the affected
child are also the blood donors for the child. Since these disorders
are hereditary in nature that means both of the parents are carriers
for the disease. Hence parents’ blood is also partly defective one
and should not be given to the patient, in general. In most of the cases,
the investigation reports vary from laboratory to laboratory due to
this fact, which create confusion to the attending physician. These
are technical and very important aspects, which should be taken care
of. Therefore, it is advisable that the patient should be sent for hematological
laboratory investigations at least one month after the blood transfusion
or immediately before blood transfusion.
It
is pathetic that the adequate treatment and management facilities are
not available for the sickle cell disease, β-thalassemia major and G6PD deficiency cases even in the capital
city of Bhubaneswar. Adequate treatment and management facilities need
to be extended to at District Headquarters Hospital level for hereditary
hemolytic disorders in the state. The accumulated genetic data have
enhanced the rapid advancement of clinical genetics in Odisha.(21-23)
Currently
in India, the emphasis is on the small family norms and the socio-economic
constraints have created a desired in all the eligible couples that
every child born should be normal. Thus, it has been emphasized that
medical genetics play a pivotal role in the clinical practice, therapy,
innovative developments, prevention, and the management of genetic diseases.
Author
is grateful to Dr. VM Katoch, Secretary, Department of Health Research,
Government of India and Director General, Indian Council of Medical
Research, New Delhi for providing the necessary facilities. Thanks are
also due to Mr. RK Mishra, Laboratory Technician for his support in
the field and laboratory work.
- Balgir RS. Serogenetc
studies in the Gypsy Sikligars of North-western India. Hum Biol
1986;58:171-187.
- Balgir RS. The spectrum of
hemoglobin variants in two scheduled tribes of Sundargarh district in
North-western Orissa, India. Ann Hum Biol 2005;32:560-573.
- Balgir RS. A Genetic study
of six typical families of the sickle cell disease in India. Int J Child
Health Hum Develop 2010;3:139-149.
- Balgir RS. Detrimental
intrinsic factors contain population explosion for sustainable development in
18 indigenous communities of Orissa, India. In: Pati RN, Jain Atul Kumar (Eds).
Biodiversity and Sustainable Development. New Delhi: Swarup Book Publishers
Private Limited 2010; pp. 507-516.
- Balgir RS. Medical genetics
in public health administration in India: A handicap of bureaucracy, bias and
corruption. Health Administrator (Theme: Health of the Educational Systems)
2005;17:101-109.
- Balgir RS. Phenotypic
diversity of sickle cell disorders with special emphasis on public health
genetics in India. Curr Sci 2010;98:1096-1102.
- Balgir RS. Human genetics in
community health practice in India: An urgent need of action. In: Sharma K,
Pathak RK, Mehta S and Talwar I (Eds.). Genes, Environment and Health:
Anthropological Perspectives. New Delhi: Serials Publications 2007;
pp.171-186.
- Balgir RS. Understanding
hemolytic intrinsic health problems in aboriginal communities of Orissa,
India: A hindrance for development. Int Res J Social Sci 2009;2:23-33.
- Balgir RS. Impact of gender
bias on health and nutrition of the tribal women in relation to dynamics of
development in India. Internet J Biol Anthropol 2009;3:1-11.
- Balgir RS. Tribal health
problems, disease burden and ameliorative challenges in the tribal communities
of Eastern Ghats with special reference to Orissa. In: Sarkar RM (Ed.)
Primitive Tribal Groups in India: Tradition, Development and Transformation.
New Delhi: Serials Publications 2008; pp.273-295.
- Balgir RS. Biomedical
anthropology in contemporary tribal society of India. In: Contemporary
Society: Tribal Studies (Tribal Situation in India). Vol.6. Behera, Deepak
Kumar, Pfeffer, Georg (Eds). New Delhi: Concept Publishing Company 2005; pp.
292-301.
- Kar BC, Kulozik AE, Sirr S,
Satapathy RK, Kulozik M, Serjeant BE, Serjeant GR. Sickle cell disease in
Orissa state, India. Lancet 1986;2:1198-1201.
- Kar BC, Devi S, Dash KC, Das
M. The sickle cell gene is widespread in India. Trans Royal Soc Trop Med
Hyg 1987;81:273-275.
- Kar BC. Sickle cell disease
in India. JAPI 1991;39:954-960.
- Balgir RS. Genetic burden of
red cell enzyme glucose-6-phosphate dehydrogenase deficiency in two major
scheduled tribes of Sundargarh district in Northwestern Orissa. Curr Sci
2006;92:768-774.
- Praharaj KC, Mohanta KD, Kar
RS, Swain U, Nanda BK. Hemoglobinopathy in Orissa. Indian Pediat
1969;6:533-537.
- Samal GC, Ahmed B, Behera
SK. Incidence of sickle cell disease. Pediat Clin India. 1978;13:33-36.
- Samal GC, Naik KN. Incidence
of sickle cell disease in school children of western Orissa. Indian J Hemat
1983;1:51-54.
- Balgir RS. Spectrum of
hemoglobinopathies in the state of Orissa, India: A ten years cohort study.
JAPI 2005;53:1021-1026.
- Balgir RS. Scenario of
hemoglobin variants in Central-East coast of India. Curr Sci
2006;90:1651-1657.
- Balgir RS. Control and
prevention of genetic load of hemoglobinopathies in India. Nat Med J India
1999;12:234-238.
- Balgir RS. Challenges of
imparting IEC for prevention of hereditary sickle cell disorders, b-thalassemia
syndrome and G6PD deficiency in India. Tribal Health Bull
2007;13:14-22.
- Balgir RS. Prevention of
hereditary disorders in India: sickle cell disease, b-thalassemia and G6PD
deficiency (in English & Oriya). Bhubaneswar: RMRC (ICMR) 2001; pp. 1-12.
- Balgir RS. Hematological
profile of twenty-nine tribal compound cases of hemoglobin-pathies and G6PD
deficiency in rural Orissa. Indian J Med Scis 2008;62:364-373.
- Balgir RS. Intervention and
prevention of hereditary hemolytic disorders in India: A case study of two
major ethnic communities of Sundargarh district in Orissa. JAPI
2008;56:851-858.
- Balgir RS. Infant mortality
and reproductive wastage associated with different genotypes of
hemoglobinopathies in Orissa, India. Ann Hum Biol 2007;34:16-25.
- Nanda BK, Panda GK, Naik UP,
Nanda CN, Praharaj KC. Hemoglobin S in Agharia community of Orissa. J
Indian Med Assocn 1967;48:150-152.
- Das SR, Mukherjee CP, Sastry
DB. Sickle cell trait in Koraput district and other parts of India. Acta
Genet Stat Med 1967;17:62-73.
- Roy DN, Roy Chaudhuri SK.
Sickle cell trait in the tribal population in Madhya Pradesh and Orissa. J
Indian Med Assocn 1967;49:107-112.
|